Inovalon (INOV) IPO Opens Up 23%

Today's IPO for Inovalon (NASDAQ: INOV) opened for trading at $33.16 after pricing 22,222,222 shares of its Class A common stock at a price to the public of $27.00 per share.

Goldman, Sachs & Co., Morgan Stanley & Co. LLC, Citigroup Global Markets Inc. are acting as joint lead book-running managers, BofA Merrill Lynch and UBS Investment Bank are also acting as book-running managers for the offering. Robert W. Baird & Co., Piper Jaffray & Co., Wells Fargo Securities, LLC and William Blair & Company, LLC are acting as co-managers.

Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. Inovalon's unique achievement of value is delivered through the effective progression of Turning Data into Insight, and Insight into Action®. Large proprietary datasets, advanced integration technologies, sophisticated predictive analytics, and deep subject matter expertise deliver a seamless, end-to-end platform of technology and nationwide operations that bring the benefits of big data and large-scale analytics to the point of care. Driven by data, Inovalon uniquely identifies gaps in care, quality, data integrity, and financial performance – while bringing to bear the unique capabilities to resolve them. Supporting hundreds of healthcare organizations in 98.2% of U.S. counties and Puerto Rico, Inovalon's analytical and data-driven intervention platforms are informed by data pertaining to more than 754,000 physicians, 248,000 clinical facilities, and more than 120 million Americans providing a powerful solution suite that drives high-value impact, improving quality and economics for health plans, ACOs, hospitals, physicians, patients and researchers.

You May Also Be Interested In

• Rubrik IPO: 5 key things to know
• Baird Adds Columbia Sportswear (COLM) to Bearish Fresh Pick List
• Ibotta (IBTA) starts trading at $118, price IPO at $88